Salivary Oxytocin as a Biomarker in Psychedelic Assisted Psychotherapy [PDF]
Introduction One of the main mechanisms of action of LSD in psychedelic-assisted psychotherapy (PAP) is the activation of 5HT2A receptors. This triggers a cascade of neurochemical processes with the release of neurotransmitters and neurohormonal substances.
Cazorla L +8 more
europepmc +3 more sources
Psychedelic assisted psychotherapy (2020–2025): a scoping review of clinical evidence, mechanisms, safety, and ethics [PDF]
BackgroundClinical research on psychedelic-assisted therapy (PAT) has expanded substantially in recent years, particularly for post-traumatic stress disorder (PTSD) and depressive disorders.
Nasiru Mohammed Abdullahi +23 more
doaj +2 more sources
Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers. [PDF]
Background: Recent regulatory changes in Australia have approved 3,4-methylenedioxymethamphetamine for treating post-traumatic stress disorder and psilocybin for treatment-resistant depression.
Nadeem Z +4 more
europepmc +2 more sources
Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems [PDF]
Elena Argento +6 more
doaj +2 more sources
Psychedelic assisted psychotherapy: a person-centred approach
This thesis explores the role of the therapist in Psychedelic-Assisted Psychotherapy (PAT) through the lens of Carl Rogers Person-Centred Therapy (PCT).
Browne, Niamh
core +3 more sources
Methodological fragmentation and integration priorities in psychedelic-assisted therapy assessment: a scoping review [PDF]
IntroductionPsychedelic-assisted therapy (PAT) is an emerging complex intervention for psychiatric and existential conditions (i.e., forms of distress related to meaning, mortality, and identity, such as that arising in life-threatening illness); however,
Maria Laura Mele +3 more
doaj +2 more sources
Conceptual analysis of mechanisms and methods in psychedelic clinical trial design: a narrative review [PDF]
Clinical trials with psychedelics face several challenges that are not present to such a degree with other pharmacotherapeutics. Psychedelic therapies often include a significant therapeutic container, including preparatory and integrative psychotherapy,
Martin Krsak +4 more
doaj +2 more sources
Extrapharmacological Safety Topics in Psychedelic-Assisted Psychotherapy
This Viewpoint proposes methods for optimizing patient and therapist safety during psychedelic-assisted psychotherapy.
Calder, Abigail, Hasler, Gregor
openaire +3 more sources
Psychedelic-assisted psychotherapy, patient vulnerability and abuses of power
Recent high-profile findings supporting the possible efficacy of psychedelic-assisted psychotherapy (Psy-AP) for indications including treatment-resistant depression and post-traumatic stress disorder make it increasingly likely that these treatments will become more widely available.
Sally Meikle +2 more
openaire +2 more sources
Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default
The acute subjective effects of psychedelics are responsive to users’ expectations and surroundings (i.e., “set and setting”). Accordingly, a great deal of thought has gone into designing the psychosocial context of psychedelic administration in clinical
David B. Yaden +5 more
doaj +1 more source

